# US 2024/0189188 A1 · Devices and methods for cornea treatment

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0189188 A1
- Document ID: US20240189188A1
- Status: Published application
- Kind: A1
- Application number: 18/444,261
- Filed: 2024-02-16
- Published: 2024-06-13
- Earliest claimed: 2022-11-30
- Assignees: D&D Biopharmaceuticals, Inc.
- Applicants: D&D Biopharmaceuticals, Inc.
- Inventors: Bruce H. DeWOOLFSON; Dale P. DeVORE; Michael LUTTRELL; Chris L. DAVIS
- Web page: https://patentgrep.com/patent/US20240189188A1

## CPC

- A61J 1/2093: {Containers having several compartments for products to be mixed}
- A61F 9/0008: {Introducing ophthalmic products into the ocular cavity or retaining products therein (putting in contact lenses A61F9/0061; introducing or retaining media in cavities of the body in general A61M31/00)}
- A61F 9/0026: {Ophthalmic product dispenser attachments to facilitate positioning near the eye}
- A61J: CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)

## Abstract

Medical devices and methods of use thereof are described. The device may include a body having a housing that defines a lumen, a piston within the housing, and an actuator operably coupled to the piston, wherein the piston is movable along the lumen by operating the actuator. The device also may include a cartridge insertable into the body and/or a flexible fitting configured for direct application to an eye of a subject.

## Claims

### Claim at position 1

1-19. (canceled)

### Claim 20

A method of treating a subject using a medical device comprising a housing and a flexible fitting, wherein the housing defines a lumen that contains a cartridge and a piston operably coupled to an actuator, and wherein the cartridge includes a first subcartridge that contains a buffer solution and a second subcartridge that contains an active agent, the method comprising:
preparing a composition by combining the buffer solution with the active agent by pressing an actuator of the device to move the piston distally to establish fluid communication between the first subcartridge and the second subcartridge;
mixing the composition, wherein a pH of the composition decreases over time;
placing the fitting against an eye of the subject, wherein the fitting flares radially outward to accommodate a convex curvature of the eye; and
administering the composition to the eye by expelling the composition into an enclosed space between the fitting and the eye.

### Claim 21 (depends on 20)

The method of claim 20, wherein the active agent is an acylating agent and the composition is administered to the eye while having a pH ranging from about 8.4 to about 8.6.

### Claim 22 (depends on 21)

The method of claim 21, wherein the active agent is a first active agent and the first subcartridge further comprises a second active agent mixed with the buffer solution, and wherein the second active agent comprises a steroid, an anti-inflammatory agent, an antihistamine, a prostaglandin, an anesthetic agent, or an antimicrobial agent.

### Claim 23 (depends on 20)

The method of claim 20, wherein the composition does not comprise a preservative.

### Claim 24 (depends on 20)

The method of claim 20, wherein establishing fluid communication between the first subcartridge and the second subcartridge includes piercing a thin foil or polymeric film between the first subcartridge and the second subcartridge.

### Claim 25 (depends on 20)

The method of claim 20, further comprising inserting the cartridge into the lumen before preparing the composition, and removing the cartridge from the lumen after administering the composition to the eye.

### Claim 26 (depends on 20)

The method of claim 20, wherein the housing includes an indicator in the form of a light source configured to emit light a predetermined amount of time after the actuator is pressed to signal the composition has reached a pH suitable for application to the eye of the subject.

### Claim 27 (depends on 26)

The method of claim 26, wherein administering the composition to the eye occurs after the light source emits light at the predetermined amount of time.

### Claim 28 (depends on 25)

The method of claim 25, wherein the housing includes a release button and the method further comprises:
removing the cartridge from the lumen after administering the composition to the eye; and
re-setting a starting position of the piston by pressing the release button to withdraw arms coupled to the release button from pockets of the piston, such that the piston moves proximally.

### Claim 29

A method of treating a subject using a medical device comprising a housing and a flexible fitting, wherein the housing defines a lumen that contains a cartridge and a piston operably coupled to an actuator, and wherein the cartridge includes a first subcartridge that contains a buffer solution and an active agent, and a second subcartridge that contains an acylating agent, the method comprising:
preparing a composition by pressing an actuator of the device to move the piston distally to establish fluid communication between the first subcartridge and the second subcartridge and thereby combine the buffer solution and the active agent with the acylating agent, wherein pressing the actuator initiates a predetermined time interval;
at an end of the predetermined time interval, placing the fitting against an eye of the subject, wherein the fitting flares radially outward to accommodate a convex curvature of the eye; and
administering the composition to the eye by expelling the composition into an enclosed space between the fitting and the eye.

### Claim 30 (depends on 29)

The method of claim 29, wherein the housing includes an indicator that provides an audio or visual signal at the end of the predetermined time interval.

### Claim 31 (depends on 29)

The method of claim 29, wherein the active agent comprises a steroid, an anti-inflammatory agent, an antihistamine, a prostaglandin, an anesthetic agent, or an antimicrobial agent.

### Claim 32 (depends on 29)

The method of claim 29, wherein the composition has a pH ranging from about 8.4 to about 8.6 at the end of the predetermined time interval.

### Claim 33 (depends on 29)

The method of claim 29, wherein the housing includes a release button and the method further comprises:
removing the cartridge from the lumen after administering the composition to the eye; and
re-setting a starting position of the piston by pressing the release button to withdraw arms coupled to the release button from pockets of the piston, such that the piston moves proximally.

### Claim 34 (depends on 33)

The method of claim 33, wherein the piston includes two pockets on opposing lateral sides of the piston.

### Claim 35 (depends on 29)

The method of claim 29, wherein the composition is held in contact with the eye for at least 30 seconds.
